Overview

Short- and Long Term Growth in Children With Asthma

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to assess if treatment with budesonide 200 microgram per day affects short- or long term growth in children with asthma
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
ChildrenĀ“s Clinic, Randers
Treatments:
Budesonide
Montelukast
Criteria
Inclusion Criteria:

- age 6-11,

- prepubertal,

- asthma,

- normal weight and height,

- informed consent

Exclusion Criteria:

- treatment with systemic/inhaled/intranasal corticosteroids within the last week,

- major surgery within 4 weeks,

- usage of drugs that significantly inhibit CYP3A4